Currently her research focus is mainly on Type 3C diabetes associated with pancreatic disease. Recent studies from this laboratory showed that β cell dysfunction exists in non diabetic chronic pancreatitis patients even before β cell apoptosis and clinical diabetes occurs in these patients. Arresting loss of β cell function in pancreatic disease and protecting β cell mass is important in the treatment of diabetes.